19206-51-0 Usage
Description
2-(2-Hydroxyethyl)benzeneboronic acid dehydrate 95, also known as glycerol benzeneboronic acid, is an organic chemical compound with the molecular formula C8H11BO4. It is a white crystalline solid that is soluble in water and has a molecular weight of 179.98 g/mol. 2-(2-HYDROXYETHYL)BENZENEBORONIC ACID DEHYDRATE 95 is an important intermediate in the synthesis of various organic compounds and has potential applications in different industries.
Uses
Used in Organic Chemical Synthesis:
2-(2-Hydroxyethyl)benzeneboronic acid dehydrate 95 is used as an organic chemical synthesis intermediate for the production of various organic compounds. Its unique chemical structure allows it to act as a building block in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-(2-Hydroxyethyl)benzeneboronic acid dehydrate 95 is used as a key intermediate in the synthesis of various drug molecules. Its ability to form stable boron-containing compounds makes it a valuable component in the development of new drugs with improved pharmacological properties.
Used in Agrochemical Industry:
2-(2-Hydroxyethyl)benzeneboronic acid dehydrate 95 is also used in the agrochemical industry as an intermediate for the synthesis of various agrochemicals, such as pesticides and herbicides. Its unique chemical properties enable the development of more effective and environmentally friendly agrochemicals.
Used in Material Science:
In the field of material science, 2-(2-Hydroxyethyl)benzeneboronic acid dehydrate 95 is used as a precursor for the synthesis of advanced materials, such as polymers and composites. Its ability to form stable boron-containing structures makes it a promising candidate for the development of new materials with improved mechanical, thermal, and electrical properties.
Check Digit Verification of cas no
The CAS Registry Mumber 19206-51-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,2,0 and 6 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 19206-51:
(7*1)+(6*9)+(5*2)+(4*0)+(3*6)+(2*5)+(1*1)=100
100 % 10 = 0
So 19206-51-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H9BO2/c10-9-8-4-2-1-3-7(8)5-6-11-9/h1-4,10H,5-6H2
19206-51-0Relevant articles and documents
An Efficient Benzoxaborole One-Pot Synthesis by SiliaCat DPP-Pd Heterogeneous Catalysis using Diboronic Acid
Kunihiro, Kana,Dumais, Laurence,Lafitte, Guillaume,Varvier, Emeric,Tomas, Lo?c,Harris, Craig S.
, p. 2757 - 2761 (2018)
Organoboron compounds are valuable molecules of increasing interest in organic synthesis, catalysis, biology and medicine. Among them, benzoxaboroles emerged as promising building blocks for numerous research programs. In this letter, we communicate the development of new conditions for the one-pot benzoxaborole synthesis by SiliaCat DPP?Pd catalysis using diboronic acid as the boron source. This low cost and sustainable strategy permitted the preparation of a useful range of benzoxaborole building blocks. Finally, the transformation was extended to a continuous flow process using our Vapourtec system. (Figure presented.).
A convenient one-pot synthesis of boroxoles from diboronic acid
Lafitte, Guillaume,Kunihiro, Kana,Bonneaud, Céline,Dréan, Bénédicte,Gaigne, Frédéric,Parnet, Véronique,Pierre, Romain,Raffin, Catherine,Vatinel, Rodolphe,Fournier, Jean-Fran?ois,Musicki, Branislav,Ouvry, Gilles,Bouix-Peter, Claire,Tomas, Loic,Harris, Craig S.
supporting information, p. 3757 - 3759 (2017/09/12)
The preparation of the boroxole motif traditionally relies on a 3-step process and the use of n-butyl lithium that can limit substrate scope. Herein during our exploration toward novel RORγ inhibitors, we identified a convenient one-pot preparation of the motif in good yields with good substrate scope.
BORON-CONTAINING SMALL MOLECULES AS ANTI-PROTOZOAL AGENT
-
Page/Page column 78, (2011/10/10)
This invention provides, among other things, novel compounds useful for treating protozoal infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent. The compounds are of the formula, wherein Y' is a halogen, Y is halosubstituted alkyl, or a salt thereof.